AstraZeneca

AZNCF | OTC

Price Alert Chart Builder DCF Calculator

$189.90

-$2.60 (-1.35%)

Mar 13, 2026, 9:30 AM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021	Q4 2020 Dec 30, 2020	Q3 2020 Sep 29, 2020	Q2 2020 Jun 29, 2020	Q1 2020 Mar 30, 2020
Revenue	14.46B	13.59B	14.89B	13.57B	12.96B	12.62B	12.34B	11.49B	11.42B	10.88B	11.21B	10.98B	10.77B	11.39B	12.01B	9.87B	8.22B	7.32B	7.41B	6.58B	6.28B	6.35B
Cost of Revenue	2.47B	2.24B	2.73B	3.08B	3.15B	3.13B	3.38B	2.1B	1.96B	1.91B	2.9B	2.98B	3B	3.51B	4.63B	3.76B	2.19B	1.86B	1.53B	1.37B	984M	1.42B
Gross Profit	11.98B	11.35B	12.17B	10.48B	9.81B	9.49B	8.96B	9.4B	9.46B	8.97B	8.31B	8B	7.77B	7.88B	7.39B	6.11B	6.03B	5.46B	5.89B	5.21B	5.29B	4.93B
Operating Income	3.51B	3.67B	2.04B	2.11B	2.85B	3.23B	1.32B	1.95B	2.46B	2.55B	1.09B	1.25B	539M	878M	-292M	-1.67B	1.13B	1.9B	1.49B	1.17B	1.28B	1.22B
Interest Income	68M	86.15M	64M	183M	100M	111M	110.82M	101M	64M	78M	45M	15M	18M	17M	1M	15M	7M	20M	7M	7M	22M	51M
Pretax Income	3.13B	3.5B	1.67B	1.83B	2.4B	2.8B	920.42M	1.65B	2.09B	2.26B	778M	922M	247M	553M	-636M	-2B	764M	1.61B	1.17B	853M	961M	935M
Net Income	2.45B	2.99B	1.5B	1.43B	1.93B	2.18B	960M	1.37B	1.82B	1.8B	901M	1.64B	360M	386M	-347M	-1.65B	550M	1.56B	1.01B	648M	756M	780M
Selling & General & Admin	5.01B	4.57B	5.55B	5.29B	5.06B	4.63B	4.65B	4.93B	5.12B	4.19B	4.78B	4.4B	4.81B	4.97B	5.24B	2.99B	3.2B	3.03B	3.32B	2.27B	2.74B	2.81B
Research & Development	3.55B	3.17B	4.68B	3.12B	3.01B	2.69B	2.99B	2.58B	2.67B	2.61B	2.63B	2.36B	2.55B	2.13B	2.58B	2.15B	1.83B	1.71B	1.72B	1.45B	1.39B	1.39B
Other Expenses	-79M	-68.95M	-100M	-25M	-3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1M	n/a	n/a	n/a	n/a
Operating Expenses	8.48B	7.67B	10.13B	8.38B	8.01B	6.26B	7.64B	7.44B	7B	6.67B	7.21B	6.59B	7.23B	7B	7.68B	7.44B	4.9B	3.56B	4.4B	3.89B	4.01B	3.71B
Interest Expense	439M	357.92M	429M	457M	443M	413M	456.62M	392M	431M	365M	360M	339M	311M	336M	312M	335M	326M	303M	321M	324M	329M	332M
Selling & Marketing Expenses	143M	132M	143M	145M	132M	135M	17.83B	129M	131M	134M	4.78B	126M	4.81B	4.97B	5.24B	2.99B	3.2B	3.03B	3.32B	2.27B	2.74B	2.81B
Cost & Expenses	10.95B	9.91B	12.86B	11.46B	10.19B	9.39B	11.02B	9.54B	8.96B	8.57B	10.11B	9.57B	10.23B	10.51B	12.3B	11.2B	7.09B	5.43B	5.92B	5.26B	4.99B	5.13B
Income Tax Expense	679M	493.29M	166M	395M	469M	617.24M	-63.62M	274M	268M	458M	-124M	-720M	-113M	165M	-290M	-350M	214M	46M	162M	202M	223M	185M
Shares Outstanding (Basic)	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.55B	1.5B	1.31B	1.31B	1.31B	1.31B	1.31B	1.31B
Shares Outstanding (Diluted)	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.55B	1.5B	1.32B	1.32B	1.31B	1.31B	1.31B	1.31B
EPS (Basic)	1.58	1.88	0.97	0.92	1.24	1.40	0.64	0.85	1.19	1.18	0.60	1.06	0.23	0.25	-0.22	-1.10	0.42	1.19	0.78	0.49	0.58	0.59
EPS (Diluted)	1.57	1.87	0.96	0.91	1.24	1.39	0.63	0.85	1.18	1.17	0.60	1.05	0.23	0.25	-0.22	-1.10	0.42	1.18	0.78	0.49	0.58	0.59
EBITDA	4.96B	5.04B	4.43B	4.1B	4.12B	4.46B	2.68B	3.22B	3.85B	3.89B	2.38B	2.46B	1.86B	2.16B	1.91B	1.1B	1.86B	2.71B	2.25B	1.98B	2B	2.11B
EBIT	3.57B	3.75B	2.1B	2.29B	2.84B	3.21B	1.31B	1.98B	2.46B	2.63B	1.12B	1.25B	539M	876.5M	-291.88M	-1.67B	1.12B	1.91B	1.45B	1.17B	1.28B	1.22B
Depreciation & Amortization	1.39B	1.28B	2.34B	1.82B	1.28B	1.25B	1.36B	1.24B	1.29B	1.52B	1.53B	1.27B	1.32B	1.28B	2.2B	2.73B	743.79M	797.47M	797M	801M	710M	841M